Observational studyMedicine2019

Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Luyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.